We analyzed the clinical outcomes in 688 patients with isolated stenosis of one major coronary artery. The survival rate among patients with disease of the right coronary artery (RCA) was higher than that among patients with left anterior descending (LAD) or left circumflex coronary artery (LCA) disease. The survival rate among patients in all three anatomic subgroups exceeded 90% at 5 years. The presence of a lesion proximal to the first septal perforator of the LAD was associated with decreased survival compared with the presence of a more distal lesion. For the entire group of one-vessel disease patients, total ischemic events (death and nonfatal infarction) occurred at similar rates regardless of the anatomic location of the lesion. Left ventricular ejection fraction was the baseline descriptor most strongly associated with survival, and the characteristics of the angina had the strongest relationship with nonfatal myocardial infarction. No differences in survival or total cardiac event rates were found with surgical or nonsurgical therapy. The relief of angina was superior with surgical therapy, although the majority of nonsurgically treated patients had significant relief of angina. The survival rate of patients with one-vessel coronary disease is excellent, and the risk of nonfatal infarction is low. Clinical strategies for the care of these patients must consider the long-term clinical course of one-vessel coronary disease.
THE PHYSICIAN treating patients with stenosis of only one major coronary artery must consider a variety of therapeutic options. Medical therapy, percutaneous coronary angioplasty, and coronary artery bypass grafting have been proposed by different authors as the treatment of choice. ' However, the information needed to compare these alternatives is either fragmentary or contradictory.2 In particular anatomic subgroups, such as patients with a lesion of the left anterior descending coronary artery (LAD) before the first septal perforator, the decision to pursue vigorous therapy has been rationalized by the presumption that the prognosis would otherwise be poor.3'4 Unfortunately, little objective information is available to substantiate this belief, and little information is available regarding prognostic end points other than death.
The purpose of this study was to describe the course of a large group of one-vessel coronary disease patients with respect to three end points: survival, total ischemic events (death and nonfatal infarction), and relief of angina. For each end point, the "natural history" of the disease in the 1970s is first reviewed by analyzing the course of nonsurgically treated patients. Then, the outcome of surgically treated patients is analyzed. From this information a strategy for the management of these patients can be defined.
Since 1969, information on all patients undergoing cardiac catheterization at Duke University Medical Center has been collected prospectively. A complete medical history, physical examination, chest x-ray and standard 12-lead ECG have been obtained on all patients. Catheterization variables describing anatomy and ventricular function have also been collected on all patients (table 1). The computerized information system used in this study has been described. 5 Follow-up information is obtained at 6 months, at 1 year, and at yearly intervals thereafter, as described previously.6 Data on each end point are collected prospectively. The criteria used to diagnose myocardial infarction in nonsurgically treated patients during the follow-up period have been published.7 A perioperative myocardial infarction was diagnosed only with the development of a new 0.04-second Q wave that remained present at the time of discharge from the hospital. Chest pain status during the follow-up period was assessed using the standard New York Heart Association (NYHA) classification. Patients One-vessel coronary artery disease was defined as 75% or greater stenosis in a major coronary vessel: LAD or large diagonal branch; left circumflex (LCA), large optional diagonal, or large marginal branch; and right coronary artery (RCA).s Stenosis of a nondominant RCA was not considered significant. Patients with 75% or greater stenosis of the left main coronary artery and patients with congenital or valvular heart disease other than mitral valve prolapse or mitral regurgitation due to ischemic heart disease were excluded. Of the 6111 patients with chest pain who underwent cardiac catheterization between November 1969 and June 1980, 688 patients met these criteria for one-vessel disease. Left ventriculography was performed in the biplane mode in 84% of the patients and in the single-plane mode in the remainder. All patients had single-plane coronary arteriography in multiple views. Results were reviewed by at least three senior angiographers on the day of cardiac catheterization. Since 1974, a detailed coronary artery tree has been completed prospectively on each patient, giving the location and percent stenosis of each lesion. Before 1974, each film was reviewed by two senior angiographers to verify the location and percent stenosis of each lesion.
The location of each lesion was classified as either in the proximal one-third or distal two-thirds of the coronary vessel. For the LAD, a further classification into lesions before or after the first major septal perforator was made. An isolated lesion of a large marginal, optional diagonal, or anterolateral vessel was recorded as a distal lesion. Percent stenosis was graded as previously described. 8 This method has been validated by an interobserver reliability study and a clinical-pathologic correlation (Trask N: personal communication).
Data Analysis
Baseline characteristics of one-vessel disease patients were compared with those of two-and threevessel disease patients evaluated at Duke University Medical Center during the same time period. Nonparametric analysis of variance was used to compare continuous characteristics and standard chi-square statistics for categorical descriptors. Similar baseline comparisons of nonsurgically and surgically treated patients with one-vessel disease were performed.
The Kaplan-Meier life-table estimates9 of survival and also of other event rates were used to summarize the follow-up experience of these patients. The entry point into the study was the time of initial cardiac cathe,terization for nonsurgical patients and the date of operation for surgical patients. The outcome events considered were cardiac death, total cardiac events (defined as cardiac death or nonfatal myocardial infarction) and achievement of NYHA class I status for angina or improvement by two functional classes after the initial cardiac catheterization. Patients who were initially treated medically and then underwent surgery were included in the life-table calculations for the nonsurgical group until the time of surgery and then their medical follow-up was censored. Eleven percent of patients who were initially treated nonsurgically crossed over to surgical therapy during the study. Patients who died of noncardiac causes were censored at the time of death.
In the analysis of chest pain, the proportion of patients who improved by two functional classes from the time of initial cardiac catheterization was computed for each follow-up time by treatment. For patients who crossed over to surgical treatment, the angina status immediately before surgery was used as the last observation in the nonsurgical record, even if the time of operation was not at the yearly follow-up time. Thus, the potential bias caused by the fact that the major reason for crossover was increasing angina was minimized.
Statistical comparisons of survival or event-free curves between two or more groups of patients were performed using the likelihood ratio test based on Breslow's formulation'0 of Cox's proportional hazards regression model." Cox's model was also used in multivariable analysis; the procedure described by Harris The baseline characteristics of the patients with onevessel coronary artery disease are compared in table 2 with the characteristics of patients evaluated at Duke during the same time period who had two-or threevessel coronary disease. The one-vessel disease group was younger, had a higher percentage of women and fewer risk factors for coronary disease. The one-vessel 284 CIRCULATION ONE-VESSIEL CAD/Califf et al. ventricular; NYHA New York disease patients also had better ventricular function than the remainder of the patients and more often had atypical and stable chest pain. A higher proportion of one-vessel disease patients had Prinzmetal's angina and NYHA class IV angina. The duration of symptoms of coronary disease was much shorter in the one-vessel disease group.
Survival
The survival of nonsurgically treated one-vessel disease patients is displayed in figure 1 according to the vessel involved. For comparison, the survival of the 1516 patients catheterized at Duke during the same time period and found to have insignificant or no coronary artery disease is also displayed. The 1-year survival rate ranges from 96% in patients with LAD disease to 99% in patients with RCA disease. Similarly, the 5-year survival ranges from 92% to 96%. The overall survival of the nonsurgically treated patients with LAD and LCA disease is not significantly different, but both are different from the survival in RCA disease (p = 0.03). The survival rate of patients with isolated RCA disease is only slightly lower than that of patients with no significant disease.
Among the baseline characteristics listed in table 1, only left ventricular ejection fraction was significantly and independently related to survival. The presence of peripheral vascular disease, the risk factors, the nonin-vasive descriptors of myocardial damage and the percent stenosis of the involved vessel were not independently related to survival in this group of patients.
The survival rate of nonsurgically treated patients with stenosis of the LAD before the first septal perforator is compared in figure 2 with that of patients with lesions after the first septal perforator. The survival rate in both groups was greater than 90% at 2 years. However, the group with lesions before the first septal perforator had a lower survival rate than the group without such lesions. At 5 years, the survival rate was 98% in patients with lesions after the first septal perforator and 90% in patients with lesions before the first septal perforator. After controlling for the effect of left ventricular ejection fraction on survival, the presence of the proximal LAD lesion remained significant (p = 0.01). In nonsurgical patients with RCA or LCA disease, proximal lesions were not associated with decreased survival compared with distal lesions.
The survival rate of the patients with one-vessel disease treated surgically is compared in figure 3 with that of patients treated nonsurgically. The survival rate in both groups was greater than 90% at 5 years. No significant differences in survival were found according to treatment, either for the overall group or for specific anatomic subgroups. The overall operative mortality rate since 1969 among one-vessel disease patients has been 4%. However, for patients with elective bypass grafting since 1972, excluding patients with aneurysm resection or mitral valve replacement 100- .0O and patients with 50% left main lesions, the operative mortality rate has abeen 0.6% (one of 160 patients). A comparison of baseline characteristics between the overall group of nonsurgically and surgically treated patients is shown in table 3. The major difference between the groups was that the surgically treated patients had more severe chest pain. In addition, women were more often treated surgically. When patients were stratified according to the severity of chest pain at the time of cardiac catheterization, again no differences in survival according to treatment were found.
Total Cardiac Events
The event-free rates in the three groups of nonsurgically treated patients are compared in figure 4 . There were no differences in total events among the three anatomic groups. For comparison, the event-free curve for the patients catheterized during the same time period and found to have insignificant or no coronary disease is also shown. Although the survival rate in patients with isolated RCA disease was only marginally different from that in patients with no significant stenosis, the total event rate was markedly higher. At 5 years, approximately 20% of the patients in each group with one-vessel disease had suffered either a nonfatal myocardial infarction or cardiac death. Analysis of the New York ratio of nonfatal infarctions to fatal events revealed that patients with one-vessel disease were more likely to have a nonfatal infarct than a fatal event.
When the baseline descriptors were related to the likelihood of a clinical event (death or nonfatal infarction), left ventricular ejection fraction, the presence of preinfarction angina (prolonged pain at rest with admission to the coronary care unit before catheterization) and Prinzmetal's angina were significant independent predictors.
The event-free rates in the nonsurgical and surgical groups are compared in figure 5 . When perioperative myocardial infarction is included in the analysis of total events, no difference between nonsurgical and surgical patients is found. If perioperative infarctions are excluded, there is a trend toward fewer total events in the surgical patients, but this difference is not statistically significant.
Relief of Angina
The proportion of nonsurgically treated patients who were in NYHA class I or improved by two functional classes after catheterization is shown in figure 6 .
No SurCo4i pts
Within 6 months of catheterization, 54% of the nonsurgically treated patients were in class I or had improved by two functional classes. This level of pain relief was 5 6 7 maintained over time. Despite a higher level of chest pain before catheterization, 81% of surgically treated ,essel coronary ar-patients were in class I or had improved 2 functional classes at 6 months ( fig. 7 ). This improvement de- ye the surgically from all five studies were pooled, the average annual y to have typical mortality rate was 2.2%. Because the mortality rate with these charfrom coronary disease is not linear over time, 12 averag-No significant ing the annual mortality rate is an inaccurate way to s achieving pain characterize coronary disease. Pooling data from studaddition, the paies in which baseline characteristics are poorly deto NYHA classiscribed adds further inaccuracy. 18 Nonetheless, the imhe time of cardipression from the studies before 1972 was that survival provement with was worse for one-vessel disease than the results of the NYHA class III present investigation indicate. A 1973 study from the van 80 mg of pro-Cleveland Clinic series'7 found survival rates similar to rization ( fig. 8) .
those in the current population in one-vessel disease patients without additional insignificant (< 75%) stento have come to oses. However, compared with the present study, a vourse of the de-much poorer survival rate was found in patients with Angina status ofpatients with one-vet artery disease taking more than 80 mg/day ofproj were in New York HeartAssociation (NYHA)functi or IV at the time of initial cardidc catheterizatioi represents the percentage of patients treated st nonsurgically who improved by at least two funct or achieved NYHA class I status.
additional insignificant stenoses. A simila Burgraaf and Parker'9 found 95% 1-year a year survival rates, compared with 97% ar spectively, in the present series. Whether th survival represents an improvement in techniques or patient selection cannot be 2 this study. One remarkable finding of our study wa: lent survival of patients with isolated RC, While patients with isolated RCA disease s cardial infarctions at a rate similar to ott with one-vessel disease, they rarely have a ac event. Thus, patients with RCA lesions c sured that they are unlikely to die over a 7-y although recurrent angina and nonfatal infa occur.
The poorer survival in LAD disease th disease is consistent with previous reports ing supports the hypothesis that the amc ventricular myocardium supplied by a vesse determinant of the risk involved when it be eased. 20 Despite the worse prognosis for isc disease compared with RCA disease in our survival for LAD patients was better than i] vious reports. The only series of nonsurgic patients with isolated LAD disease and beti was reported by Kouchoukos et al.21 Thei cluded only 24 nonsurgically treated patient age follow-up was 3.5 years and there was ity. Other series have reported annual morta 2.3-7.7%. 18, 19, 22, 23 The similar survival with LCA and LAD stenosis has not bee previously because of small numbers of pa isolated LCA stenosis.
Apart from the location of the coronary 1i the ejection fraction had a significant indepe tionship to survival. In the entire group of nx ly treated patients with one-vessel and multivessel coronary disease at this institution, other factors, such as the severity of chest pain, clinical indicators of myocardial damage and the presence of peripheral vas-40) cular disease, were strongly related to survival.'2 The fact that these characteristics did not relate to survival independently in one-vessel disease patients is probi 32) ably a result of few deaths and the relative infrequency of abnormal values of these characteristics among onevessel disease patients. 104 pts)
When the location of the lesion within each vessel cal 123 pts (proximal vs distal) was investigated, the only impor-r tant location with respect to survival was found to be 4 5 the lesion before the first septal perforator in the LAD. 29 If coronary artery bypass grafting is required in relief of chest pain, it can be done at little risk. The operative risk of patients with severe ventricular dysfunction appears to be substantially higher, even in one-vessel disease, although the number of patients in this study is too small for statistical comparison. The finding that the total event rate in nonsurgically treated patients was equal regardless of the vessel involved supports the concept that the occurrence of coronary occlusion (by any one of a number of mechanisms) is equally likely given a significant baseline stenosis, regardless of the exact location of the lesion. The chest pain characteristics (preinfarction angina and Prinzmetal's angina) emerged as important predictors of subsequent infarction. The higher likelihood of nonfatal infarction compared with death as an initial event in one-vessel disease confirms previous work from this laboratory.7
Interpretation of the data on total events cannot be complete until the prognostic importance of perioperative myocardial infarction is determined. Previous reports have indicated that patients with perioperative myocardial infarction are at increased risk of subsequent cardiac death compared with surgical patients without perioperative infarction.30' 31 Whether a perioperative infarction carries the same risk as a nonfatal infarction occurring outside of the setting of coronary artery bypass grafting is unclear.
The resolution of chest pain in these patients with either medical or surgical therapy is gratifying. The excellent result with surgical therapy was expected based on previous reports.32 ' 3 The results of medical therapy in this low-risk group of patients have not been emphasized previously. We used the term "nonsurgical" therapy instead of medical therapy because many of the patients were not treated at our institution during the entire follow-up period. No standard treatment protocol was used. The dosage of nitrate and propranolol therapy varied widely, depending upon the year of entry into the study and the wishes of the patient and the referring physician.
The chest pain information in the nonsurgically treated patients must be interpreted with care. More of these patients were in NYHA class I or II and fewer had progressive angina before catheterization compared with surgically treated patients. Furthermore, the patients who developed severe chest pain during the follow-up period were often referred for surgery. Nonetheless, with initial nonsurgical therapy, a large percentage of these patients became less symptomatic.
The results of surgical and nonsurgical therapy over 11 years at our institution support a conservative approach to the management of one-vessel coronary disease. Patients with RCA disease have an excellent survival rate with nonsurgical therapy, as do patients with distal LAD disease. Patients with LCA disease have a survival rate with medical therapy between that of RCA and LAD patients, but closer to that of LAD patients. Left ventricular dysfunction is the most significant predictor of survival, and the characteristics of -the angina symptoms are most strongly associated with total ischemic events. Chest pain relief is remarkably good with standard medical therapy. If.chest pain is limiting the patient, surgery can be performed at an extremely low risk, resulting in excellent relief of angina. The patients with proximal LAD lesions have a prognosis that is better than previously believed, although they have a higher risk of death than other patients with one-vessel.disease. The prolonged survival of patients with one-vessel disease underscores the concept that one-vessel coronary artery disease should be considered a chronic disease. When planning.a therapeutic strategy, the physician and patient should recognize that although mortality is low, the symptoms of coronary disease may recur over a period of many years.
